Open AccessPatients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
Author(s) -
C. Visco,
A. Tzankov,
Zijun Y. Xu-Monette,
R. N. Miranda,
Y. C. Tai,
Y. Li,
W.-m. Liu,
Emanuele S G d'Amore,
Y. Li,
S. Montes-Moreno,
K. Dybkaer,
A. Chiu,
A. Orazi,
Y. Zu,
G. Bhagat,
H.-Y. Wang,
C. H. Dunphy,
E. D. His,
X. F. Zhao,
W. W. Choi,
X. Zhao,
J. Han van Krieken,
Q. Huang,
W. Ai,
S. O'Neill,
M. Ponzoni,
A. J. Ferreri,
B. S. Kahl,
J. N. Winter,
R. S. Go,
S. Dirnhofer,
M. A. Piris
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/q7jx-g862
Subject(s) - diffuse large b cell lymphoma , rituximab , germinal center , oncology , center (category theory) , chop , medicine , lymphoma , outcome (game theory) , chromosomal translocation , b cell , immunology , biology , genetics , gene , chemistry , antibody , mathematics , crystallography , mathematical economics